-
Fund Dashboard
- Holdings
Tema Oncology ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 2.65 mm | 28.63 k shares | 5.42 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 2.64 mm | 3.52 k shares | 5.39 | Common equity | Long | USA |
AZN AstraZeneca PLC | 2.55 mm | 18.86 k shares | 5.21 | Common equity | Long | UK |
RVMD Revolution Medicines, Inc. | 2.23 mm | 38.52 k shares | 4.56 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 2.12 mm | 21.96 k shares | 4.33 | Common equity | Long | USA |
ARGX argenx SE | 2.09 mm | 3.39 k shares | 4.27 | Common equity | Long | Netherlands |
INCY Incyte Corporation | 2.07 mm | 27.71 k shares | 4.23 | Common equity | Long | USA |
ILMN Illumina, Inc. | 1.87 mm | 13.00 k shares | 3.83 | Common equity | Long | USA |
Chugai Pharmaceutical Co Ltd
|
1.64 mm | 37.14 k shares | 3.35 | Common equity | Long | Japan |
Daiichi Sankyo Co Ltd
|
1.52 mm | 47.96 k shares | 3.11 | Common equity | Long | Japan |
EXEL Exelixis, Inc. | 1.47 mm | 40.19 k shares | 3.00 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 1.40 mm | 13.74 k shares | 2.86 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 1.39 mm | 23.47 k shares | 2.85 | Common equity | Long | USA |
ONC BeiGene, Ltd. | 1.23 mm | 5.71 k shares | 2.51 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 1.21 mm | 23.59 k shares | 2.47 | Common equity | Long | Switzerland |
GH Guardant Health, Inc. | 1.17 mm | 32.94 k shares | 2.40 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 1.17 mm | 28.11 k shares | 2.38 | Common equity | Long | USA |
MREO Mereo BioPharma Group plc | 1.15 mm | 319.01 k shares | 2.35 | Common equity | Long | UK |
GMAB Genmab A/S | 1.04 mm | 48.42 k shares | 2.13 | Common equity | Long | Denmark |
NUVL Nuvalent, Inc. | 1.02 mm | 10.60 k shares | 2.10 | Common equity | Long | USA |
Novartis AG
|
990.98 k | 9.36 k shares | 2.03 | Common equity | Long | Switzerland |
DAWN Day One Biopharmaceuticals, Inc. | 888.55 k | 63.79 k shares | 1.82 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 850.43 k | 13.70 k shares | 1.74 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 785.39 k | 50.28 k shares | 1.61 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 775.46 k | 8.81 k shares | 1.59 | Common equity | Long | USA |
SDGR Schrödinger, Inc. | 767.49 k | 34.01 k shares | 1.57 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 738.03 k | 26.90 k shares | 1.51 | Common equity | Long | USA |
AMGN Amgen Inc. | 691.33 k | 2.44 k shares | 1.41 | Common equity | Long | USA |
LNTH Lantheus Holdings, Inc. | 648.55 k | 7.27 k shares | 1.33 | Common equity | Long | USA |
MRUS Merus N.V. | 592.61 k | 13.22 k shares | 1.21 | Common equity | Long | Netherlands |
Siemens Healthineers AG
|
587.61 k | 10.84 k shares | 1.20 | Common equity | Long | Germany |
LEGN Legend Biotech Corporation | 582.54 k | 13.85 k shares | 1.19 | Common equity | Long | USA |
BNTX BioNTech SE | 486.46 k | 4.11 k shares | 0.99 | Common equity | Long | Germany |
NRIX Nurix Therapeutics, Inc. | 455.13 k | 20.59 k shares | 0.93 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 450.33 k | 47.35 k shares | 0.92 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 443.87 k | 9.82 k shares | 0.91 | Common equity | Long | USA |
First American Treasury Obligations Fund | 426.26 k | 426.26 k shares | 0.87 | Short-term investment vehicle | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 410.66 k | 41.48 k shares | 0.84 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 400.96 k | 14.66 k shares | 0.82 | Common equity | Long | USA |
MRNA Moderna, Inc. | 372.12 k | 8.64 k shares | 0.76 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 364.22 k | 17.85 k shares | 0.74 | Common equity | Long | UK |
CGEM Cullinan Oncology, Inc. | 348.81 k | 25.93 k shares | 0.71 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 334.21 k | 10.21 k shares | 0.68 | Common equity | Long | UK |
RCUS Arcus Biosciences, Inc. | 313.09 k | 20.28 k shares | 0.64 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 277.11 k | 58.96 k shares | 0.57 | Common equity | Long | USA |
TERN Terns Pharmaceuticals, Inc. | 274.23 k | 43.95 k shares | 0.56 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 264.03 k | 7.60 k shares | 0.54 | Common equity | Long | USA |
CRBP Corbus Pharmaceuticals Holdings, Inc. | 260.26 k | 14.61 k shares | 0.53 | Common equity | Long | USA |
JSPR Jasper Therapeutics, Inc. | 258.83 k | 11.35 k shares | 0.53 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 238.10 k | 8.91 k shares | 0.49 | Common equity | Long | USA |